Ca2+-Dependent Intracellular Drug Delivery System Developed with “Raspberry-Type” Particles-on-a-Particle Comprising Mesoporous Silica Core and α-Synuclein-Coated Gold Nanoparticles
Source abstract
Abstract
For the development of an intracellular cargo release system with mesoporous silica nanoparticles (MSN), gold nanoparticles coated with an amyloidogenic protein of α-synuclein were employed to prepare a protein-mediated nanocomposite into the "raspberry-type" particles-on-a-particle (PoP). The PoPs were successfully fabricated only at pH 4.4 by yielding the MSN coverage to 75.3% with 5 nm gold nanoparticles covalently coated with a mutant form of α-synuclein containing a cysteine residue at the C-terminus. The entrapped cargo of rhodamine 6G was shown to be selectively released from PoPs upon exposure to divalent cations including the α-synuclein-specific pathophysiological ligand of Ca(2+). Intracellular uptake of the PoPs preloaded with doxorubicin as an anticancer drug and its subsequent Ca(2+)-dependent release were demonstrated with HeLa cells in the presence of intracellular Ca(2+)-regulating agents. Therefore, the fabrication of PoPs with the self-interactive protein of α-synuclein is expected to serve as a platform technology for preparation of diversified nanocomposites with various nanoparticles and/or bioactive molecules for eventual applications in the areas of theranostics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Advanced Drug Delivery Systems · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemical and Biological Engineering, Institute of Chemical Processes, College of Engineering, Seoul National University, Seoul 151-744, Republic of Korea
Center for Nanoparticle Research, Institute for Basic Science, Seoul 151-744, Republic of Korea
Funding
Ministry of Education · Ministry of Science, ICT and Future Planning
References (38)
Show source-provided references
1. Cheng Z. · Science · 2012 · 338 · 90310.1126/science.1226338 ↗
2. Nie S. · Annu. Rev. Biomed. Eng. · 2007 · 9 · 25710.1146/annurev.bioeng.9.060906.152025 ↗
3. Colilla M. · Biomater. Sci. · 2013 · 1 · 11410.1039/C2BM00085G ↗
4. Tarn D. · Acc. Chem. Res. · 2013 · 46 · 79210.1021/ar3000986 ↗
5. Lu J. · Small · 2010 · 6 · 179410.1002/smll.201000538 ↗
6. He Q. · J. Mater. Chem. · 2011 · 21 · 584510.1039/c0jm03851b ↗
7. Chen Y. · Adv. Mater. · 2013 · 25 · 314410.1002/adma.201205292 ↗
8. Lee J. E. · Acc. Chem. Res. · 2011 · 44 · 89310.1021/ar2000259 ↗
9. Lee C.-H. · Angew. Chem., Int. Ed. · 2010 · 49 · 821410.1002/anie.201002639 ↗
10. Slowing I. I. · Adv. Drug Delivery Rev. · 2008 · 60 · 127810.1016/j.addr.2008.03.012 ↗
11. Park C. · Angew. Chem., Int. Ed. · 2007 · 46 · 145510.1002/anie.200603404 ↗
12. Hong C.-Y. · J. Mater. Chem. · 2009 · 19 · 515510.1039/b820534e ↗
13. Kim H. · Adv. Mater. · 2010 · 22 · 428010.1002/adma.201001417 ↗
14. Gruenhagen J. A. · Appl. Spectrosc. · 2005 · 59 · 42410.1366/0003702053641513 ↗
15. Mal N. K. · Nature · 2003 · 421 · 35010.1038/nature01362 ↗
16. Chen P.-J. · J. Mater. Chem. · 2011 · 21 · 253510.1039/c0jm02590a ↗
17. Lai C.-Y. · J. Am. Chem. Soc. · 2003 · 125 · 445110.1021/ja028650l ↗
18. Gan Q. · Biomaterials · 2011 · 32 · 193210.1016/j.biomaterials.2010.11.020 ↗
19. Liu R. · J. Am. Chem. Soc. · 2010 · 132 · 150010.1021/ja907838s ↗
20. Sun X. · J. Am. Chem. Soc. · 2011 · 133 · 1855410.1021/ja2080168 ↗
21. Martin-Ortigosa S. · Adv. Funct. Mater. · 2012 · 22 · 357610.1002/adfm.201200359 ↗
22. Volles M. J. · Biochemistry · 2003 · 42 · 787110.1021/bi030086j ↗
23. Lee D. · Langmuir · 2011 · 27 · 1278210.1021/la203124e ↗
24. Lee J. E. · J. Am. Chem. Soc. · 2010 · 132 · 55210.1021/ja905793q ↗
25. Lowe R. · Protein Sci. · 2004 · 13 · 324510.1110/ps.04879704 ↗
26. Nath S. · Mol. Cell. Neurosci. · 2011 · 46 · 51610.1016/j.mcn.2010.12.004 ↗
27. Monteith G. R. · Nat. Rev. Cancer. · 2007 · 7 · 51910.1038/nrc2171 ↗
28. Leal S. S. · Coord. Chem. Rev. · 2012 · 256 · 225310.1016/j.ccr.2012.04.004 ↗
29. Uversky V. N. · J. Biol. Chem. · 2001 · 276 · 4428410.1074/jbc.M105343200 ↗
30. Tamamizu-Kato S. · Biochemistry · 2006 · 45 · 1094710.1021/bi060939i ↗
31. Sung Y.-H. · BBA-Proteins Proteomics · 2006 · 1764 · 510.1016/j.bbapap.2005.11.003 ↗
32. Bisaglia M. · Neuromol. Med. · 2009 · 11 · 23910.1007/s12017-009-8082-1 ↗
33. Harding M. M. · Acta. Crystallogr. D Biol. Crystallogr. · 2004 · 60 · 84910.1107/S0907444904004081 ↗
34. Binolfi A. · Coord. Chem. Rev. · 2012 · 256 · 218810.1016/j.ccr.2012.05.004 ↗
35. Zhou S. · Cytokine · 2010 · 52 · 21010.1016/j.cyto.2010.07.003 ↗
36. Jan C.-R. · Life Sci. · 1999 · 64 · 25910.1016/S0024-3205(98)00561-X ↗
37. Lee D. · Angew. Chem., Int. Ed. · 2011 · 50 · 133210.1002/anie.201004301 ↗
38. Haiss W. · Anal. Chem. · 2007 · 79 · 421510.1021/ac0702084 ↗